Schulich school of Medicine and Dentistry logo Gastroenterology Schulich School of Medicine & Dentistry

Karim Qumosani

QumosaniKpic115150.jpg

Contact Information

University Hospital, 339 Windermere Road, London, Ontario N6A 5A5, Rm A10-227
Tel: 519.663.3976
Fax: 519.663.2907

Research Interests/Specialization

Liver Transplantation

Dr. Karim Qumosani is an Associate Professor of Medicine at Western University. He is also the Program Director of the Gastroenterology Fellowship Program and the Director of the Advanced Hepatology and Liver Transplantation Fellowship program at London Health Sciences Centre. He completed his MD at King Abdulaziz University and his Internal Medicine and Gastroenterology fellowship at Western University. Dr. Qumosani trained in Advanced Motility and Advance Hepatology and Liver Transplantation at Western University. Clinically, his expertise is in Liver Transplantation, Cirrhosis related complications and Immune mediated Liver Disease. His research focuses primarily on Chronic Hepatitis C, Cirrhosis and Hepatocellular Carcinoma. Dr. Qumosani has a strong passion for teaching and mentoring in the area of medical education. His passion for continued medical education stems mainly from the huge steps forward in respect to learning modalities.

 

Recent Publications

Al Draiweesh S, Ma C, Alkhattabi M, McDonald C, Nguyen T, Beatoon M, Chande N, Colquhoun P, Feagan B, Gregor J, Khanna R, Marotta P, Ponich T, Quan D, Qumosani K, Sandhu A, Sey M, Skaro A, Teriaky A, Wilson A, Yan B, Brahmania M, Jairath V. Safety of Combination Biologic and Anti-Rejection Therapy Post-Liver Transplantation in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Disease, 2019 Jul 2, Coauthor [submitted]

Al-Judaibi B, Alqalami I, Sey M, Qumosani K, Howes N, Hernandez-Alejandro R, Chandok N, Eddin A, Marotta P, Teriaky A. Exercise Training for Liver Transplant Candidates. Journal of Hepatology; 2019. Coauthor

Aldraiweesh S, Sandhu A, Ma C, Gregor J, Alkhattabi M, Brahmania M, Chande N, Khanna R, Jairath V, Teriaky A, Feagan B, Qumosani K, Marotta P. Safety on Combination Biologic and Anti-rejection Therapy Post-Liver Transplantation in Patients with Inflammatory Bowel Disease: London Ontario Experience. ECCO; 2018. Coauthor

Qumosani K, Salman A, Marotta P, Driman D, Parfitt J. Recurrent Hepatocellular Carcinoma After Liver Transplantation: Validation of a Pathological Risk Score on Explanted Livers to Predict Recurrence. 2018 Aug, Senior Responsible Author

Parvathy S, Beaton M, Meddings J, Rahman A, Tat-Ko J, Qumosani K, Craven L, Burton J, Silverman M. Impact of Fecal Microbial Transplantation on Intestinal Permeability in Non-Alcoholic Fatty Liver Disease. Digestive Disease Week 2018; 2018 Jun 3, Washington, United States; 2018. Coauthor

Alzahrani M, Walsh J, Qumosani K, Teriaky A. Fever, Cholestatic Hepatitis and Pneumonia, A Common Presentation of Uncommon Disease: Case report and Literature Review. Canadian Digestive Diseases Week; 2018 Feb; 2018. Senior Responsible Author

Alghamdi W, Qumosani K. Triple Overlap Syndrome? A Rare Case of AIH, PBC and PSC Overlap. Canadian Digestive Diseases Week; 2018 Feb; 2018. Senior Responsible Author
Alotaibi A, Alghamdi W, Marotta P, Qumosani K. Hepatocellular Carcinoma Prevalence in Non-Cirrhotic Hepatitis C Patients. Canadian Digestive Diseases Week; 2018 Feb; 2018. Senior Responsible Author

Sadkhan H, Tawfic Q, Dhir A, Qumosani K, Morrison S, Kumar K, Armstrong K. Post operative pain management of Orthotopic liver transplantation (OLT): Retrospective study. CAS 2017; 2017 Jun 23; Niagara Falls, Ontario, Canada; 2017. Coauthor

Tat-ko J, Beaton M, Parvathy S, Craven L, Burton J, Rahman A, Joy T, Qumosani K, Silverman M. Evaluating Patient Interest in Fecal Transplantation for Non-Alcoholic Fatty Liver Disease. Association of Medical Microbiology and Infectious Disease Canada; 2017 May 4, Ontario, Canada; 2017. Coauthor

Teriaky A, Mosli M, Chandok N, Tashkandi A, Al Judaibi B, Marotta P, Qumosani K. Prevalence of fat soluble vitamins (A,D, and E) and zinc deficiency in patients with cirrhosis being assessed for liver transplant. Acta Gastro-Enterologica, 2017 Jan; 80 (2), Coauthor

Aljudaibi B, Qumosani K, Chandok N. Pentoxifylline for slow to resolve hepatopulmonary syndrome post liver transplantation: helpful or unnecessary? Acta Gastro-enterologica. 2013 Mar 7, Impact Factor: 1.62, Co-Principal Author

Zahreini Z, Qumosani K. Outcomes of liver transplantation for acute liver failure among recipients with abo-iden-tical vs. abo-compatible vs. abo-incompatible grafts. Canadian Digestive Diseases Week; 2017 Mar; 2017. Senior Responsible Author

Thomas B, Al Judaibi B, Adams P, Marotta P, Levstik M, Qumosani K. The impact of sofosbuvir-based therapy on renal function in hepatitis c virus patients with advanced liver disease. Canadian Digestive Diseases Week; 2017 Mar; 2017. Senior Responsible Author

Alfawaz M, Sinclair L, Hilwah M, Al Judaibi B, Marotta P, Qumosani K. Using beside ultrasound as a tool to detect sarcopenia for cirrhotic patients on transplant list. Canadian Digestive Diseases Week; 2017 Mar; 2017. Senior Responsible Author

Alageeli M, Qumosani K. Pancreatobiliary Cancer with Unusual Site of Metastasis. Canadian Digestive Diseases Week; 2017 Mar; 2017. Senior Responsible Author

Al Ibrahim B, Qumosani K. Infliximab induced autoimmune hepatitis: Two cases with different outcome. Canadian Digestive Diseases Week; 2017 Mar; 2017. Senior Responsible Author

Alghanem m, Driman D, Bashir O, Al Judaibi B, Kakani N, Marotta P, Qumosani K. Hepatocellular Carcinoma Response to Local Regional Therapy; Correlations Between Pre-Liver Transplant Imaging and Explant Pathology. Journal of Gastrointestinal and Digestive System, 2016 Jun 29; 6 (3), Principal Author

Thomas B, Adams P, Marotta P, Levstik M, Qumosani K, Al Judaibi B. Analysis of Safety and Efficacy of Sofosbuvir-Based Therapy in Liver Transplant Assessed Hepatitis C Patient. Canadian Digestive Diseases Week; 2016. Coauthor

Sandhu A, Al Judaibi B, Qumosani K, Burton J, Reid G, Rahman A. Efficacy of Probiotic Therapy in Preventing Overt Hepatic Encephalopathy: A Review. Canadian Digestive Diseases Week; 2015. Coauthor

Qumosani K, Alghanem M, Marotta P, Al Judaibi B, Driman D, Garisa M, Bashir O, Kakani N. Hepatocellular Carcinoma Response to Local Regional Therapy, Correlation Between Pre-Liver Transplants Imaging and Explant Pathology. Canadian Digestive Diseases Week; 2015. Principal Author

Shaikh T, Ma M, Abraldes J, Ameen R, Shah A, Robbins S, Qumosani K, Al Judaibi B, Rahman A, Tandon P. Nutrition and Physical Therapy Targets are not Being Met in Admitted Patients with Cirrhosis. Canadian Digestive Diseases Week; 2015. Coauthor

Alijawad M, Marotta P, Qumosani K. Poor Influenza Vaccine Uptake in Liver Transplant. Canadian Digestive Diseases Week; 2015. Principal Author

Alawad Y, Al Judaibi B, Dale C, Qumosani K, Marotta P. The Safety and Efficacy of Local Regional Therapies in Elderly Patients with Hepatocellular Carcinoma. Canadian Digestive Diseases Week; 2015. Coauthor

Thomas B, Marotta P, Adams P, Schwarz U, Qumosani K, Levstik M, Kim R, Al Judaibi B. Thiopurine Methyltransferase Genotype Among Patients with Autoimmune Hepatitis Treated with Azathioprine. Canadian Digestive Diseases Week; 2015. Coauthor

Aljawad M, Marotta P, Qumosani K, Al Judaibi B. Influenza Vaccination In Cirrhotic Patients: Uptake and Barriers. Canadian Digestive Diseases Week; 2015. Coauthor

Teriaky A, Mosli M, Chandok N, Tashkandi A, Al Judaibi B, Marotta P, Qumosani K. Prevalence of fat soluble vitamins (A,D, and E) and zinc deficiency in patients with end-stage liver disease being assessed for liver transplantation. Can J Gastroenterol; 2014. Senior Responsible Author

Qumosani K, Garsia M, Driman D, Bashir O, Al Judaibi B, Kakani N, Marotta P. Hepatocellular Carcinoma response to local regional therapy; correlation between pre-liver transplantation radiological imaging to histopathological finding post-liver transplant. Can J Gastroenterol; 2014. Principal Author

Teriaky A, Mosli M, Chandok N, Qumosani K. Prevalence of fat-soluble vitamin(A, D, and E) and zinc deficiency in patients with cirrhosis being assessed for liver transplantation. AASLD. 2014 May 14, Impact Factor: 1.62, Senior Author

Mosli M, Croome K, Qumosani K, Aljudaibi B, Marotta P, Beaton M and Chandok N. The Effect of Liver Transplantation for Primary Sclerosing Cholangitis on Disease Activity in Patients with Inflammatory Bowel Disease. Gastroenterology & Hepatology, 2013 Jul 1; 9 (7). Impact Factor: 3.3, Coauthor